data_2b8f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2b8f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.73 143.56 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 172.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -145.5 156.77 43.93 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.558 1.143 . . . . 10.0 109.696 -165.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.4 mm -76.22 158.21 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.913 -1.143 . . . . 10.0 107.913 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -120.46 2.55 10.75 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.565 0.746 . . . . 10.0 111.751 -165.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.16 158.11 32.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.578 1.551 . . . . 10.0 108.881 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.47 146.56 53.06 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.992 0.517 . . . . 10.0 109.891 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.73 -158.81 31.85 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.263 -0.735 . . . . 10.0 111.263 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.53 139.13 53.45 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.795 -1.558 . . . . 10.0 106.795 172.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.7 tp -82.98 79.23 9.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.458 0.703 . . . . 10.0 109.971 -167.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -34.84 -56.01 0.56 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.532 2.333 . . . . 10.0 113.195 -171.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -148.2 164.48 33.82 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.259 1.024 . . . . 10.0 109.14 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.08 148.38 27.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.208 -1.775 . . . . 10.0 106.208 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -126.48 2.28 6.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.234 0.614 . . . . 10.0 112.65 -168.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.88 166.46 3.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.811 1.245 . . . . 10.0 110.95 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -149.14 161.24 42.38 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.744 2.018 . . . . 10.0 106.616 171.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.85 132.46 53.42 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.22 -7.55 78.23 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.633 1.111 . . . . 10.0 113.362 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -71.63 172.13 10.23 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.257 1.528 . . . . 10.0 110.062 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.78 144.0 51.08 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.6 1.16 . . . . 10.0 108.241 175.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 pt -128.89 163.27 34.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.869 1.268 . . . . 10.0 108.269 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -134.55 145.43 48.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.405 -1.702 . . . . 10.0 106.405 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.6 tttp -49.27 126.0 12.05 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.307 0.643 . . . . 10.0 110.174 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.3 -7.14 79.8 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.476 -1.18 . . . . 10.0 114.16 178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.14 144.97 56.87 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.745 1.772 . . . . 10.0 108.233 170.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.19 148.5 47.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.45 0.7 . . . . 10.0 109.788 168.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.69 -31.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.924 0.89 . . . . 10.0 111.545 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.8 178.66 9.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.106 1.362 . . . . 10.0 107.834 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.71 146.95 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.193 -2.151 . . . . 10.0 105.193 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -123.4 125.25 44.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.883 2.073 . . . . 10.0 106.249 -171.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -95.13 123.13 38.46 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.664 -1.606 . . . . 10.0 106.664 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 t -167.4 167.18 14.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.417 -1.327 . . . . 10.0 107.417 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 55.7 mtm 55.89 29.07 13.48 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.968 0.907 . . . . 10.0 112.123 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 49.62 38.71 15.61 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.82 1.648 . . . . 10.0 112.362 -171.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.8 mtt -138.96 176.04 9.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.594 1.957 . . . . 10.0 108.222 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -120.98 139.44 53.27 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.281 -1.748 . . . . 10.0 106.281 165.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.46 132.29 20.81 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 105.964 -1.865 . . . . 10.0 105.964 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.22 157.22 62.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.882 1.721 . . . . 10.0 110.878 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.6 mm -121.92 132.65 70.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.365 -2.457 . . . . 10.0 104.365 172.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.67 152.46 32.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.851 0.86 . . . . 10.0 109.534 -172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.51 123.98 22.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.943 0.897 . . . . 10.0 109.149 -174.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.28 -23.82 67.14 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.307 0.643 . . . . 10.0 111.951 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -158.18 159.72 36.42 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.064 1.746 . . . . 10.0 108.098 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.2 m -74.41 162.21 29.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.088 0.555 . . . . 10.0 110.704 171.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.76 168.56 24.86 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.339 0.495 . . . . 10.0 112.512 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.2 mm -76.01 139.77 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 106.327 -1.731 . . . . 10.0 106.327 163.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.85 117.34 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -81.86 -41.51 20.89 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 123.554 0.741 . . . . 10.0 109.704 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -160.05 159.13 31.63 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.02 133.15 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 105.778 -1.934 . . . . 10.0 105.778 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -100.58 -2.08 33.81 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.073 0.949 . . . . 10.0 112.07 -170.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -138.19 172.93 12.19 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.973 1.309 . . . . 10.0 109.778 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -145.7 167.68 22.53 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.954 1.302 . . . . 10.0 108.837 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -54.87 128.09 31.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.228 1.011 . . . . 10.0 109.404 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 0.1 88.69 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.31 -1.272 . . . . 10.0 114.177 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -71.82 154.09 41.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.947 1.874 . . . . 10.0 110.82 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.01 143.07 56.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.241 -0.652 . . . . 10.0 109.241 172.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 m -145.24 162.86 12.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.305 1.042 . . . . 10.0 109.401 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.04 171.42 16.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.122 0.569 . . . . 10.0 111.358 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -62.74 120.52 11.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.865 -0.791 . . . . 10.0 108.865 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.28 0.55 90.19 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.553 1.073 . . . . 10.0 112.879 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -78.47 128.95 34.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.043 1.421 . . . . 10.0 108.755 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.9 t -65.18 143.97 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.52 0.728 . . . . 10.0 110.42 -169.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.1 tp -103.14 -48.66 3.96 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.26 1.824 . . . . 10.0 109.394 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 pp -160.31 170.39 21.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.518 0.727 . . . . 10.0 111.121 -170.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -132.11 156.93 45.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.878 2.071 . . . . 10.0 107.221 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.76 162.26 27.82 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.218 -0.926 . . . . 10.0 110.689 -167.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.8 m -88.3 27.3 1.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.84 0.856 . . . . 10.0 109.593 167.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -151.19 12.78 0.66 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.577 1.951 . . . . 10.0 110.893 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 p -77.38 42.68 0.35 Allowed 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.202 -1.562 . . . . 10.0 113.46 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 2.286 42.2 m 82.03 28.24 0.15 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.332 1.234 . . . . 10.0 114.332 152.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . 0.27 1.5 mt-30 . . . . . 0 C--O 1.249 1.059 0 O-C-N 117.898 -3.001 . . . . 10.0 112.773 64.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.73 143.56 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 172.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -145.5 156.77 43.93 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.558 1.143 . . . . 10.0 109.696 -165.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.4 mm -76.22 158.21 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.913 -1.143 . . . . 10.0 107.913 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -120.46 2.55 10.75 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.565 0.746 . . . . 10.0 111.751 -165.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.16 158.11 32.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.578 1.551 . . . . 10.0 108.881 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.47 146.56 53.06 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.992 0.517 . . . . 10.0 109.891 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.73 -158.81 31.85 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.263 -0.735 . . . . 10.0 111.263 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.53 139.13 53.45 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.795 -1.558 . . . . 10.0 106.795 172.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.7 tp -82.98 79.23 9.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.458 0.703 . . . . 10.0 109.971 -167.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -34.84 -56.01 0.56 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.532 2.333 . . . . 10.0 113.195 -171.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -148.2 164.48 33.82 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.259 1.024 . . . . 10.0 109.14 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.08 148.38 27.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.208 -1.775 . . . . 10.0 106.208 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -126.48 2.28 6.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.234 0.614 . . . . 10.0 112.65 -168.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.88 166.46 3.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.811 1.245 . . . . 10.0 110.95 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -149.14 161.24 42.38 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.744 2.018 . . . . 10.0 106.616 171.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.85 132.46 53.42 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.22 -7.55 78.23 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.633 1.111 . . . . 10.0 113.362 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -71.63 172.13 10.23 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.257 1.528 . . . . 10.0 110.062 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.78 144.0 51.08 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.6 1.16 . . . . 10.0 108.241 175.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 pt -128.89 163.27 34.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.869 1.268 . . . . 10.0 108.269 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -134.55 145.43 48.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.405 -1.702 . . . . 10.0 106.405 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.6 tttp -49.27 126.0 12.05 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.307 0.643 . . . . 10.0 110.174 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.3 -7.14 79.8 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.476 -1.18 . . . . 10.0 114.16 178.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.14 144.97 56.87 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.745 1.772 . . . . 10.0 108.233 170.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.19 148.5 47.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.45 0.7 . . . . 10.0 109.788 168.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.69 -31.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.924 0.89 . . . . 10.0 111.545 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.8 178.66 9.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.106 1.362 . . . . 10.0 107.834 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.71 146.95 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.193 -2.151 . . . . 10.0 105.193 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -123.4 125.25 44.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.883 2.073 . . . . 10.0 106.249 -171.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -95.13 123.13 38.46 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.664 -1.606 . . . . 10.0 106.664 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 t -167.4 167.18 14.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.417 -1.327 . . . . 10.0 107.417 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 55.7 mtm 55.89 29.07 13.48 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.968 0.907 . . . . 10.0 112.123 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 49.62 38.71 15.61 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.82 1.648 . . . . 10.0 112.362 -171.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.8 mtt -138.96 176.04 9.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.594 1.957 . . . . 10.0 108.222 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -120.98 139.44 53.27 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.281 -1.748 . . . . 10.0 106.281 165.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.46 132.29 20.81 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 105.964 -1.865 . . . . 10.0 105.964 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.22 157.22 62.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.882 1.721 . . . . 10.0 110.878 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.6 mm -121.92 132.65 70.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.365 -2.457 . . . . 10.0 104.365 172.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.67 152.46 32.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.851 0.86 . . . . 10.0 109.534 -172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.51 123.98 22.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.943 0.897 . . . . 10.0 109.149 -174.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.28 -23.82 67.14 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.307 0.643 . . . . 10.0 111.951 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -158.18 159.72 36.42 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.064 1.746 . . . . 10.0 108.098 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.2 m -74.41 162.21 29.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.088 0.555 . . . . 10.0 110.704 171.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.76 168.56 24.86 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.339 0.495 . . . . 10.0 112.512 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.2 mm -76.01 139.77 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 106.327 -1.731 . . . . 10.0 106.327 163.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.85 117.34 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -81.86 -41.51 20.89 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 123.554 0.741 . . . . 10.0 109.704 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -160.05 159.13 31.63 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.02 133.15 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 105.778 -1.934 . . . . 10.0 105.778 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -100.58 -2.08 33.81 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.073 0.949 . . . . 10.0 112.07 -170.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -138.19 172.93 12.19 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.973 1.309 . . . . 10.0 109.778 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -145.7 167.68 22.53 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.954 1.302 . . . . 10.0 108.837 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -54.87 128.09 31.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.228 1.011 . . . . 10.0 109.404 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 0.1 88.69 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.31 -1.272 . . . . 10.0 114.177 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -71.82 154.09 41.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.947 1.874 . . . . 10.0 110.82 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.01 143.07 56.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.241 -0.652 . . . . 10.0 109.241 172.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 m -145.24 162.86 12.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.305 1.042 . . . . 10.0 109.401 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.04 171.42 16.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.122 0.569 . . . . 10.0 111.358 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -62.74 120.52 11.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.865 -0.791 . . . . 10.0 108.865 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.28 0.55 90.19 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.553 1.073 . . . . 10.0 112.879 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -78.47 128.95 34.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.043 1.421 . . . . 10.0 108.755 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.9 t -65.18 143.97 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.52 0.728 . . . . 10.0 110.42 -169.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.1 tp -103.14 -48.66 3.96 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.26 1.824 . . . . 10.0 109.394 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 pp -160.31 170.39 21.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.518 0.727 . . . . 10.0 111.121 -170.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -132.11 156.93 45.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.878 2.071 . . . . 10.0 107.221 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.76 162.26 27.82 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.218 -0.926 . . . . 10.0 110.689 -167.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.8 m -88.3 27.3 1.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.84 0.856 . . . . 10.0 109.593 167.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -151.19 12.78 0.66 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.577 1.951 . . . . 10.0 110.893 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 p -77.38 42.68 0.35 Allowed 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.202 -1.562 . . . . 10.0 113.46 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 2.286 42.2 m 82.03 28.24 0.15 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.332 1.234 . . . . 10.0 114.332 152.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . 0.27 1.5 mt-30 . . . . . 0 C--O 1.249 1.059 0 O-C-N 117.898 -3.001 . . . . 10.0 112.773 64.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.73 143.56 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 172.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -145.5 156.77 43.93 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.558 1.143 . . . . 10.0 109.696 -165.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.4 mm -76.22 158.21 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.913 -1.143 . . . . 10.0 107.913 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -120.46 2.55 10.75 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.565 0.746 . . . . 10.0 111.751 -165.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.16 158.11 32.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.578 1.551 . . . . 10.0 108.881 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.47 146.56 53.06 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.992 0.517 . . . . 10.0 109.891 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.73 -158.81 31.85 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.263 -0.735 . . . . 10.0 111.263 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.53 139.13 53.45 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.795 -1.558 . . . . 10.0 106.795 172.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.7 tp -82.98 79.23 9.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.458 0.703 . . . . 10.0 109.971 -167.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -34.84 -56.01 0.56 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.532 2.333 . . . . 10.0 113.195 -171.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -148.2 164.48 33.82 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.259 1.024 . . . . 10.0 109.14 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.08 148.38 27.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.208 -1.775 . . . . 10.0 106.208 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -126.48 2.28 6.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.234 0.614 . . . . 10.0 112.65 -168.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.88 166.46 3.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.811 1.245 . . . . 10.0 110.95 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -149.14 161.24 42.38 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.744 2.018 . . . . 10.0 106.616 171.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.85 132.46 53.42 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.22 -7.55 78.23 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.633 1.111 . . . . 10.0 113.362 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -71.63 172.13 10.23 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.257 1.528 . . . . 10.0 110.062 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.78 144.0 51.08 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.6 1.16 . . . . 10.0 108.241 175.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 pt -128.89 163.27 34.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.869 1.268 . . . . 10.0 108.269 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -134.55 145.43 48.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.405 -1.702 . . . . 10.0 106.405 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.6 tttp -49.27 126.0 12.05 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.307 0.643 . . . . 10.0 110.174 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.3 -7.14 79.8 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.476 -1.18 . . . . 10.0 114.16 178.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.14 144.97 56.87 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.745 1.772 . . . . 10.0 108.233 170.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.19 148.5 47.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.45 0.7 . . . . 10.0 109.788 168.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.69 -31.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.924 0.89 . . . . 10.0 111.545 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.8 178.66 9.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.106 1.362 . . . . 10.0 107.834 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.71 146.95 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.193 -2.151 . . . . 10.0 105.193 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -123.4 125.25 44.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.883 2.073 . . . . 10.0 106.249 -171.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -95.13 123.13 38.46 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.664 -1.606 . . . . 10.0 106.664 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 t -167.4 167.18 14.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.417 -1.327 . . . . 10.0 107.417 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 55.7 mtm 55.89 29.07 13.48 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.968 0.907 . . . . 10.0 112.123 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 49.62 38.71 15.61 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.82 1.648 . . . . 10.0 112.362 -171.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.8 mtt -138.96 176.04 9.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.594 1.957 . . . . 10.0 108.222 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -120.98 139.44 53.27 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.281 -1.748 . . . . 10.0 106.281 165.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.46 132.29 20.81 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 105.964 -1.865 . . . . 10.0 105.964 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.22 157.22 62.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.882 1.721 . . . . 10.0 110.878 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.6 mm -121.92 132.65 70.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.365 -2.457 . . . . 10.0 104.365 172.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.67 152.46 32.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.851 0.86 . . . . 10.0 109.534 -172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.51 123.98 22.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.943 0.897 . . . . 10.0 109.149 -174.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.28 -23.82 67.14 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.307 0.643 . . . . 10.0 111.951 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -158.18 159.72 36.42 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.064 1.746 . . . . 10.0 108.098 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.2 m -74.41 162.21 29.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.088 0.555 . . . . 10.0 110.704 171.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.76 168.56 24.86 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.339 0.495 . . . . 10.0 112.512 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.2 mm -76.01 139.77 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 106.327 -1.731 . . . . 10.0 106.327 163.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.85 117.34 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -81.86 -41.51 20.89 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 123.554 0.741 . . . . 10.0 109.704 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -160.05 159.13 31.63 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.02 133.15 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 105.778 -1.934 . . . . 10.0 105.778 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -100.58 -2.08 33.81 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.073 0.949 . . . . 10.0 112.07 -170.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -138.19 172.93 12.19 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.973 1.309 . . . . 10.0 109.778 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -145.7 167.68 22.53 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.954 1.302 . . . . 10.0 108.837 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -54.87 128.09 31.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.228 1.011 . . . . 10.0 109.404 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 0.1 88.69 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.31 -1.272 . . . . 10.0 114.177 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -71.82 154.09 41.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.947 1.874 . . . . 10.0 110.82 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.01 143.07 56.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.241 -0.652 . . . . 10.0 109.241 172.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 m -145.24 162.86 12.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.305 1.042 . . . . 10.0 109.401 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.04 171.42 16.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.122 0.569 . . . . 10.0 111.358 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -62.74 120.52 11.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.865 -0.791 . . . . 10.0 108.865 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.28 0.55 90.19 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.553 1.073 . . . . 10.0 112.879 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -78.47 128.95 34.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.043 1.421 . . . . 10.0 108.755 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.9 t -65.18 143.97 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.52 0.728 . . . . 10.0 110.42 -169.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.1 tp -103.14 -48.66 3.96 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.26 1.824 . . . . 10.0 109.394 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 pp -160.31 170.39 21.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.518 0.727 . . . . 10.0 111.121 -170.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -132.11 156.93 45.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.878 2.071 . . . . 10.0 107.221 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.76 162.26 27.82 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.218 -0.926 . . . . 10.0 110.689 -167.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.8 m -88.3 27.3 1.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.84 0.856 . . . . 10.0 109.593 167.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -151.19 12.78 0.66 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.577 1.951 . . . . 10.0 110.893 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 p -77.38 42.68 0.35 Allowed 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.202 -1.562 . . . . 10.0 113.46 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 2.286 42.2 m 82.03 28.24 0.15 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.332 1.234 . . . . 10.0 114.332 152.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . 0.27 1.5 mt-30 . . . . . 0 C--O 1.249 1.059 0 O-C-N 117.898 -3.001 . . . . 10.0 112.773 64.806 . . . . . . . . 1 1 . 1 stop_ save_